Efficacy and safety of Camosunate for the treatment of uncomplicated malaria in the University of Benin Teaching Hospital, Benin City, Nigeria

Submitted: 28 March 2013
Accepted: 17 May 2013
Published: 30 October 2013
Abstract Views: 9461
PDF: 1810
HTML: 14309
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

In Nigeria, nearly 110 million clinical cases of malaria are diagnosed per year, thus being a major public health problem. The problems of resistance resulted in the introduction of the artemisinin based combinations (ACT) by the WHO. Artesunate and amodiaquine (AS+AQ) is at present the world’s second most widely used ACT. This study is an assessment of the efficacy and safety of Camosunate (a brand of AS+AQ; Geneith Pharmaceutical Ltd., Oshodi, Lagos) in the treatment of uncomplicated malaria conducted at the University of Benin Teaching Hospital (UBTH). A cross-sectional assessment of the efficacy and safety of Camosunate was conducted over a period of one year using 120 patients selected after stratification, by random sampling technique. All recruited patients had slide-proven uncom- plicated malaria and were followed up for 28 days on commencement of Camosunate. Data was collected using a structured interviewer- administered questionnaire and was analysed using SPSS version 15. The overall efficacy of Camosunate was found to be 95.8%. Treatment was well tolerated as testified by the fact that there was no case withdrawal due to adverse drug reaction (ADR) or treatment emergent signs and symptoms (TESS). Also no evidence of toxicity was recorded. Camosunate is highly efficacious and well tolerated in this area of Nigeria and justifies its use as a first line treatment for uncomplicated malaria.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Supporting Agencies

Geneith Pharmaceutical Ltd., Oshodi, Lagos
Damien Uyagu, Department of Family Medicine, University of Benin Teaching Hospital, Benin City

Chief Consultant

Department of Family Medicine, University of Benin Teaching Hospital Benin-City, Nigeria.

Augustine Omoigberale, Department of Child Health, University of Benin Teaching Hospital, Benin City

Chief Consultant

Department of Child Health, University of Benin Teaching Hospital Benin-City, Nigeria.

Paul Dienye, Department of Family Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt

Chief Consultant,

Dept of Family Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt.

How to Cite

Uyagu, D., Omoigberale, A., & Dienye, P. (2013). Efficacy and safety of Camosunate for the treatment of uncomplicated malaria in the University of Benin Teaching Hospital, Benin City, Nigeria. Healthcare in Low-Resource Settings, 1(2), e22. https://doi.org/10.4081/hls.2013.e22